Delivery Order HHSN271201500005I-HHSN27100005
Award Date
2/5/16
Potential Completion Date
6/29/22
Potential Value
$1.2M
Federal Agency
National Institute on Drug Abuse
Awardee
Curia Global Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Albany, NY 12212, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Curia Global Inc. (doing business as Amri), a for-profit manufacturer, under the Drug Manufacturing and Formulation Program (DMFP) indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. The $725,724.21 cost-plus-fixed-fee contract has an ultimate completion date of June 30, 2021 and does not have a set-aside designation. Curia, a leading global contract development and manufacturing...
This is a delivery order award to Curia Global Inc., doing business as Amri, under the Drug Manufacturing and Formulation Program (DMFP) IDIQ contract with the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services. The $219,167.73 cost-plus-fixed-fee award has a performance period through September 24, 2024 and does not include a set-aside designation. Curia, a leading global contract development and manufacturing organization, will provide...
This is a federal delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Curia Global Inc. (doing business as Amri), a for-profit manufacturer. The $160,419.00 cost-plus-fixed-fee contract is part of NIDA's Drug Manufacturing and Formulation Program (DMFP) Indefinite Delivery, Indefinite Quantity (IDIQ) master contract and has a period of performance through June 4, 2025. The contract does not have a small business set-aside designation. Curia...
This is a delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Curia Global Inc. (doing business as Amri), a for-profit manufacturer. The contract is part of the larger Drug Manufacturing and Formulation Program (DMFP) Indefinite Delivery, Indefinite Quantity (IDIQ) master contract vehicle. The award is for $1,135,799.54 and covers feasibility studies, clinical trial readiness activities, and good manufacturing practice (GMP)/clinical trial...
This is a delivery order under the Drug Manufacturing and Formulation Program (DMFP) Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract, awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency. The contract was awarded to Curia Global Inc. (doing business as Amri), a for-profit organization and manufacturer of goods. The contract provides $282,676.92 for technical support services related to the DMFP, with a period of performance from January 15,...
This contract award to Curia Global Inc. (doing business as Amri) is for the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke's Drug Manufacturing and Formulation Program (DMFP). It is a cost-plus-fixed-fee delivery order under an Indefinite Delivery/Indefinite Quantity (IDIQ) master contract, with a potential value of $3,133,295.33 and a completion date of September 12, 2029. As a global contract...
This is a delivery order under the Drug Manufacturing and Formulation Program (DMFP) IDIQ contract, awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency. The prime contractor is Curia Global Inc., doing business as Amri, a leading global contract development and manufacturing organization (CDMO) that provides a wide range of pharmaceutical research and development services to the federal government. The contract, valued at $3,140,340.00, has no...
This is a $3,453,835.19 delivery order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) to Curia Global Inc., doing business as Amri, a for-profit manufacturer. The contract is for the Medicinal Chemistry Support Program for Therapeutic Development, which provides chemistry, manufacturing, and controls development; exploratory chemistry; hit-to-lead chemistry;...
This is a $53,718,942.02 Cost Plus Fixed Fee definitive contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the National Institutes of Health (NIH), to Curia Global Inc. (doing business as Amri). The contract is for the Medicinal Chemistry for Neurotherapeutics Program (MCNP), which supports the development of small molecule drug candidates for neurological disorders. Curia, a global contract development and manufacturing organization...
This is a delivery order contract awarded by the National Institute of Mental Health (NIMH) to Curia Global Inc., doing business as Amri, a leading contract development and manufacturing organization (CDMO). The contract is part of the Medicinal Chemistry Support Program for Therapeutic Development (MCSP) and is for exploratory chemistry research related to Alzheimer's disease. The contract has a ceiling value of $607,397.30 and a performance period ending on June 2, 2025. The contract is a...